SCHEMBL7779828

SCHEMBL7779828

NC(=O)c1c(N[C]=O)ccc2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.45
GAA P10253 2/20 0.45
METAP2 P50579 2/20 0.42
METAP1 P53582 1/20 0.42
POLB P06746 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TP53 P04637 1/20 0.40
BLM P54132 1/20 0.40
SIRT2 Q8IXJ6 1/20 0.39
SIRT1 Q96EB6 1/20 0.39
SIRT3 Q9NTG7 1/20 0.39
MAPK8 P45983 1/20 0.37
CYP1A2 P05177 3/20 0.37
CYP2C19 P33261 3/20 0.37
GLA P06280 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10881652 0.81 KDM4E (0.49) KDM4EGAAMETAP2METAP1POLB
SCHEMBL8468822 0.77 IDO1 (0.47) KDM4EGAAMETAP2METAP1POLB
SCHEMBL29486321 0.72 WDR5 (0.50) KDM4EGAAPOLBSMN1; SMN2ALDH1A1
SCHEMBL1803539 0.72 ABCG2 (0.54) KDM4EGAAPOLBALDH1A1MEN1
SCHEMBL27590889 0.72 WDR5 (0.50) KDM4EGAAPOLBSMN1; SMN2ALDH1A1
SCHEMBL8761584 0.72 KDM4E (0.40) KDM4EGAAMETAP2METAP1POLB
SCHEMBL4619493 0.72 ALDH1A1 (0.45) KDM4EGAAPOLBSMN1; SMN2ALDH1A1
SCHEMBL599946 0.72 WDR5 (0.50) KDM4EGAAPOLBSMN1; SMN2ALDH1A1
SCHEMBL1803536 0.72 KDM4E (0.44) KDM4EGAAMETAP2METAP1POLB
SCHEMBL8761442 0.72 KDM4E (0.40) KDM4EGAAMETAP2METAP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5756530-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G. D. SEARLE & CO. (US) 1998-05-26 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed